X4 Pharmaceuticals, Inc.
XFOR
$0.21
-$0.0016-0.76%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 102.06M | 134.98M | 168.75M | 80.87M | 114.22M |
| Total Receivables | 1.71M | 1.07M | 854.00K | 702.00K | 562.00K |
| Inventory | 2.82M | 2.45M | 831.00K | -- | -- |
| Prepaid Expenses | 5.59M | 4.48M | 4.98M | 5.76M | 7.05M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 250.00K |
| Total Current Assets | 112.18M | 142.97M | 175.42M | 87.33M | 122.08M |
|
|
|||||
| Total Current Assets | 112.18M | 142.97M | 175.42M | 87.33M | 122.08M |
| Net Property, Plant & Equipment | 4.84M | 5.29M | 5.68M | 6.01M | 6.40M |
| Long-term Investments | 17.35M | 17.35M | 17.35M | 17.35M | 17.35M |
| Goodwill | 17.35M | 17.35M | 17.35M | 17.35M | 17.35M |
| Total Other Intangibles | 10.00M | 10.19M | 10.38M | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.08M | 2.36M | 1.79M | 1.49M | 1.44M |
| Total Assets | 146.45M | 178.17M | 210.61M | 112.18M | 147.26M |
|
|
|||||
| Total Accounts Payable | 8.62M | 8.58M | 7.99M | 8.94M | 8.95M |
| Total Accrued Expenses | 23.01M | 19.46M | 19.74M | 13.47M | 12.82M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.25M | 1.22M | 1.17M | 1.13M | 1.10M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 32.88M | 29.26M | 28.90M | 23.54M | 22.86M |
|
|
|||||
| Total Current Liabilities | 32.88M | 29.26M | 28.90M | 23.54M | 22.86M |
| Long-Term Debt | 75.43M | 75.22M | 75.03M | 54.82M | 54.57M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.41M | 1.76M | 2.03M | 2.32M | 2.61M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 14.59M | 12.31M | 10.20M | 30.46M | 16.12M |
| Total Liabilities | 124.30M | 118.54M | 116.16M | 111.15M | 96.16M |
|
|
|||||
| Common Stock & APIC | 537.63M | 535.27M | 533.45M | 530.86M | 529.12M |
| Retained Earnings | -515.36M | -475.53M | -438.84M | -529.67M | -477.91M |
| Treasury Stock & Other | -122.00K | -114.00K | -159.00K | -155.00K | -119.00K |
| Total Common Equity | 22.15M | 59.62M | 94.45M | 1.04M | 51.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 22.15M | 59.62M | 94.45M | 1.04M | 51.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 22.15M | 59.62M | 94.45M | 1.04M | 51.10M |
|
|
|||||
